A detailed history of Overbrook Management Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Overbrook Management Corp holds 140,908 shares of RPRX stock, worth $3.42 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
140,908
Previous 200,412 29.69%
Holding current value
$3.42 Million
Previous $5.28 Million 24.56%
% of portfolio
0.91%
Previous 1.33%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$25.63 - $29.27 $1.53 Million - $1.74 Million
-59,504 Reduced 29.69%
140,908 $3.99 Million
Q2 2024

Jul 25, 2024

SELL
$26.26 - $29.9 $234,685 - $267,216
-8,937 Reduced 4.27%
200,412 $5.28 Million
Q1 2024

Apr 15, 2024

SELL
$27.46 - $31.33 $283,606 - $323,576
-10,328 Reduced 4.7%
209,349 $6.36 Million
Q4 2023

Feb 02, 2024

SELL
$26.21 - $29.22 $2.07 Million - $2.31 Million
-79,035 Reduced 26.46%
219,677 $6.17 Million
Q3 2023

Nov 13, 2023

SELL
$26.26 - $31.38 $6.7 Million - $8 Million
-255,005 Reduced 46.05%
298,712 $8.11 Million
Q2 2023

Aug 11, 2023

SELL
$29.6 - $36.56 $741,953 - $916,412
-25,066 Reduced 4.33%
553,717 $17 Million
Q1 2023

May 12, 2023

SELL
$32.77 - $39.4 $1 Million - $1.2 Million
-30,569 Reduced 5.02%
578,783 $20.9 Million
Q4 2022

Feb 13, 2023

SELL
$39.17 - $44.04 $765,773 - $860,982
-19,550 Reduced 3.11%
609,352 $24.1 Million
Q3 2022

Nov 10, 2022

SELL
$39.88 - $44.65 $2.84 Million - $3.18 Million
-71,169 Reduced 10.17%
628,902 $25.3 Million
Q2 2022

Aug 11, 2022

SELL
$37.53 - $44.22 $869,907 - $1.02 Million
-23,179 Reduced 3.2%
700,071 $29.4 Million
Q1 2022

May 16, 2022

SELL
$37.46 - $42.44 $220,077 - $249,335
-5,875 Reduced 0.81%
723,250 $28.2 Million
Q4 2021

Feb 14, 2022

SELL
$35.17 - $42.48 $1.97 Million - $2.38 Million
-56,007 Reduced 7.13%
729,125 $29.1 Million
Q3 2021

Nov 12, 2021

BUY
$36.14 - $42.24 $1.01 Million - $1.18 Million
28,011 Added 3.7%
785,132 $28.4 Million
Q2 2021

Aug 13, 2021

SELL
$39.85 - $46.63 $559,254 - $654,405
-14,034 Reduced 1.82%
757,121 $31 Million
Q1 2021

May 17, 2021

SELL
$42.34 - $52.82 $311,453 - $388,543
-7,356 Reduced 0.94%
771,155 $33.6 Million
Q4 2020

Feb 16, 2021

BUY
$36.12 - $50.05 $24.2 Million - $33.6 Million
670,759 Added 622.5%
778,511 $39 Million
Q3 2020

Nov 16, 2020

BUY
$38.56 - $48.36 $4.15 Million - $5.21 Million
107,752 New
107,752 $4.53 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Overbrook Management Corp Portfolio

Follow Overbrook Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Overbrook Management Corp with notifications on news.